NOVARTIS AG (NVSEF)
Clinical trial NCT06931691 updates: 1. completion date: 2027-04-20 → 2027-04-21 2. primary completion date: 2027-04-20 → 2027-04-21
Clinical trial NCT06931691 updates: 1. completion date: 2027-04-20 → 2027-04-21 2. primary completion date: 2027-04-20 → 2027-04-21
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical